Clinical trial
A Open-Label Study of the Transition to Rivaroxaban From Low-Molecular Weight Heparin for Venous Thromboembolism Prophylaxis After Total Joint Replacement: The Safe Simple Transitions Study
NCT01094886 is registered in ClinicalTrials.gov with Ortho-McNeil Janssen Scientific Affairs, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Open-Label Study of the Transition to Rivaroxaban From Low-Molecular Weight Heparin for Venous Thromboembolism Prophylaxis After Total Joint Replacement: The Safe Simple Transitions Study
- Lead sponsor
- Ortho-McNeil Janssen Scientific Affairs, LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- December 31, 2010
- Enrollment
- 56 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.